Digital intervention may prevent type 2 diabetes in high-risk adults
The VA|PREVENTION project aimed to prevent type 2 diabetes in high-risk adults using a digital intervention. Participants showed improvements in walking and dietary behaviors.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
The VA|PREVENTION project aimed to prevent type 2 diabetes in high-risk adults using a digital intervention. Participants showed improvements in walking and dietary behaviors.
This study examined the effects of fish oil-derived omega-3 fatty acids on gut microbiota and serum lipid metabolites in individuals with Type 2 Diabetes Mellitus (T2DM). The fish oil group showed significant improvements in various metabolic markers compared to the corn oil control group.
Low-GI Mediterranean-style eating patterns in adults with metabolic syndrome.
This study investigated the effects of magnesium-containing deep seawater mineral extracts on insulin resistance in patients with impaired glucose tolerance, showing improvements in several insulin-related markers.
The study evaluated the effects of a diabetes-specific nutritional formula (DSNF-Pro) on postprandial glycemic control in prediabetic participants, finding significant reductions in glucose and c-peptide levels compared to a standard formula.
This study investigated the impact of a regular exercise program on sleep habits in children with Type 1 Diabetes, revealing significant improvements in various sleep-related outcomes.
This study compared high-dose and standard-dose influenza vaccines in older adults with diabetes, finding that HD-IIV reduced hospitalizations for various diseases.
The AWARD-11 trial compared the effects of Dulaglutide 3.0 mg and 4.5 mg to 1.5 mg on body weight in patients with type 2 diabetes, finding significant weight reductions.
This study examined the impact of hybrid closed-loop insulin therapy on insulin delivery patterns in youth with type 1 diabetes, finding a significant decrease in bolus insulin use.
The study evaluated the impact of iGlarLixi on treatment satisfaction in adults with Type 2 Diabetes, showing improvements in satisfaction scores and time in range.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.